Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs

MeSH terms

• Benzoates / administration & dosage*
• Bone Marrow Cells* / metabolism
• Bone Marrow Cells* / pathology
• Female
• Follow-Up Studies
• Humans
• Hydrazines / administration & dosage*
• Male
• Middle Aged
• Purpura, Thrombocytopenic, Idiopathic* / drug therapy
• Purpura, Thrombocytopenic, Idiopathic* / metabolism
• Purpura, Thrombocytopenic, Idiopathic* / pathology
• Pyrazoles / administration & dosage*
• Receptors, Fc / administration & dosage*
• Recombinant Fusion Proteins / administration & dosage*
• Retrospective Studies
• Thrombopoietin / administration & dosage*